Xia N - Search Results

1

Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China.

Wei L, Xie X, Liu J, Qiao Y, Zhao F, Wu T, Zhang J, Ma D, Kong B, Chen W, Zhao C, Zhao Y, Li J, Li M, Xia N. Wei L, et al. Among authors: xia n. Indian J Gynecol Oncol. 2021;19(3):51. doi: 10.1007/s40944-021-00536-6. Epub 2021 Jun 27. Indian J Gynecol Oncol. 2021. PMID: 34222614 Free PMC article. Review.

2

Immune response induced by a different combined immunization of HBsAg vaccine.

Wu T, Chen M, Ou SH, Cheng T, Zhang J, Xia NS. Wu T, et al. Intervirology. 2007;50(5):336-40. doi: 10.1159/000107044. Epub 2007 Aug 14. Intervirology. 2007. PMID: 17700028

3

[Expression, purification and immunogenicity analysis of HPV type 18 virus-like particles from Escherichia coli].

Xie M, Li S, Shen W, Li Z, Zhuang Y, Mo X, Gu Y, Wu T, Zhang J, Xia N. Xie M, et al. Among authors: xia n. Sheng Wu Gong Cheng Xue Bao. 2009 Jul;25(7):1082-7. Sheng Wu Gong Cheng Xue Bao. 2009. PMID: 19835152 Chinese.

4

Safety of the hepatitis E vaccine for pregnant women: a preliminary analysis.

Wu T, Zhu FC, Huang SJ, Zhang XF, Wang ZZ, Zhang J, Xia NS. Wu T, et al. Hepatology. 2012 Jun;55(6):2038. doi: 10.1002/hep.25522. Hepatology. 2012. PMID: 22161542 No abstract available.

5

Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity.

Zhang J, Li SW, Wu T, Zhao Q, Ng MH, Xia NS. Zhang J, et al. Rev Med Virol. 2012 Sep;22(5):339-49. doi: 10.1002/rmv.1719. Epub 2012 May 30. Rev Med Virol. 2012. PMID: 22645002 Review.

6

Hepatitis E vaccine development: a 14 year odyssey.

Wu T, Li SW, Zhang J, Ng MH, Xia NS, Zhao Q. Wu T, et al. Hum Vaccin Immunother. 2012 Jun;8(6):823-7. doi: 10.4161/hv.20042. Epub 2012 Jun 1. Hum Vaccin Immunother. 2012. PMID: 22699438

7

Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy.

Zhao Q, Zhang J, Wu T, Li SW, Ng MH, Xia NS, Shih JW. Zhao Q, et al. J Gastroenterol. 2013 Feb;48(2):159-68. doi: 10.1007/s00535-012-0701-1. Epub 2012 Nov 13. J Gastroenterol. 2013. PMID: 23149436 Free PMC article. Review.

8

Development of the hepatitis E vaccine: from bench to field.

Zhang J, Shih JW, Wu T, Li SW, Xia NS. Zhang J, et al. Semin Liver Dis. 2013 Feb;33(1):79-88. doi: 10.1055/s-0033-1338116. Epub 2013 Apr 5. Semin Liver Dis. 2013. PMID: 23564392 Review.

9

Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open-label phase I clinical trial.

Hu YM, Huang SJ, Chu K, Wu T, Wang ZZ, Yang CL, Cai JP, Jiang HM, Wang YJ, Guo M, Liu XH, Huang HJ, Zhu FC, Zhang J, Xia NS. Hu YM, et al. Hum Vaccin Immunother. 2014;10(2):469-75. doi: 10.4161/hv.26846. Epub 2013 Oct 25. Hum Vaccin Immunother. 2014. PMID: 24161937 Free PMC article. Clinical Trial.

10

Correlation between ELISA and pseudovirion-based neutralisation assay for detecting antibodies against human papillomavirus acquired by natural infection or by vaccination.

Zhao H, Lin ZJ, Huang SJ, Li J, Liu XH, Guo M, Zhang J, Xia NS, Pan HR, Wu T, Li CG. Zhao H, et al. Hum Vaccin Immunother. 2014;10(3):740-6. doi: 10.4161/hv.27619. Epub 2014 Jan 2. Hum Vaccin Immunother. 2014. PMID: 24384608 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,399 results

Search Page